Skip to main content

Table 1 Patients' characteristics

From: Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study

Characteristics

Number of patients

Percentage

Patients treated

29

-

Age

  

Median

57

-

Range

35–72

-

Gender

  

Male

21

72.4

Female

8

27.6

Histological subtype

  

Squamous carcinoma

11

37.9

Adenocarcinoma

18

62.1

Stage

  

IIIa (T2N2M0/T3N2M0)

12 (8/4)

41.4

IIIb (T2N3M0/T4N1M0/T4N2M0)

17 (2/8/7)

58.6

ECOG performance status

  

0

12

41.4

1

12

41.4

2

5

17.2

Prior chemotherapy (cycles)

  

Gemcitabine and cisplatin

14 (46)

48.3%

Vinorelbine and cisplatin

8 (21)

27.6%

Paclitaxel and cisplatin

7 (26)

24.1%

Prior radiotherapy

11

37.9%